The store will not work correctly when cookies are disabled.
Sodium 5-methylbenzo[h]isoquinoline-8-carboxylate
ID: ALA4855827
PubChem CID: 137464086
Max Phase: Preclinical
Molecular Formula: C15H10NNaO2
Molecular Weight: 237.26
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc2cc(C(=O)[O-])ccc2c2cnccc12.[Na+]
Standard InChI: InChI=1S/C15H11NO2.Na/c1-9-6-11-7-10(15(17)18)2-3-13(11)14-8-16-5-4-12(9)14;/h2-8H,1H3,(H,17,18);/q;+1/p-1
Standard InChI Key: RNCGWSRINBVKLE-UHFFFAOYSA-M
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
37.1451 -16.2118 0.0000 Na 0 0 0 0 0 15 0 0 0 0 0 0
31.3531 -13.5001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3520 -14.3238 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.0642 -14.7328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0624 -13.0871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7751 -13.4965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7759 -14.3197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1921 -13.4897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4788 -13.0822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1968 -14.3159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4853 -14.7230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4852 -15.5415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1958 -15.9538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9081 -15.5376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9047 -14.7204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6214 -15.9476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6245 -16.7689 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.3317 -15.5322 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.4745 -12.2609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
7 11 1 0
10 8 1 0
8 9 2 0
9 6 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 10 2 0
14 16 1 0
16 17 2 0
16 18 1 0
9 19 1 0
M CHG 2 1 1 18 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 237.26 | Molecular Weight (Monoisotopic): 237.0790 | AlogP: 3.39 | #Rotatable Bonds: 1 |
Polar Surface Area: 50.19 | Molecular Species: ACID | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.17 | CX Basic pKa: 5.23 | CX LogP: 1.82 | CX LogD: -0.16 |
Aromatic Rings: 3 | Heavy Atoms: 18 | QED Weighted: 0.66 | Np Likeness Score: -0.10 |
References
1. (2020) Anti-cancer/anti-fibrosis compounds, |